Common Contracts
26 similar null contracts by Biogen Inc., Cardiovascular Systems Inc, Cellular Biomedicine Group, Inc., others
REKOR SYSTEMS, INC. And ARGENT INSTITUTIONAL TRUST COMPANY, as Trustee INDENTURE Dated as of December 15, 2023Rekor Systems, Inc. • December 15th, 2023 • Communications equipment, nec • New York
INDENTURE, dated as of December 15, 2023, by and between Rekor Systems, Inc., a Delaware corporation, as Issuer (the “Company”), and Argent Institutional Trust Company, as Trustee (the “Trustee”).
MingZhu Logistics Holdings Limited and , as Trustee FORM OF INDENTURE Dated as of ,MingZhu Logistics Holdings LTD • October 12th, 2022 • Transportation services • New York
INDENTURE, dated as of , , by and between MingZhu Logistics Holdings Limited., a Cayman Islands corporation, as Issuer (the “Company”) and , a organized under the laws of , as Trustee (the “Trustee”).
CYTEIR THERAPEUTICS, INC. and U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION, as Trustee INDENTURE Dated as of [ ], [ ]Cyteir Therapeutics, Inc. • August 8th, 2022 • Pharmaceutical preparations • New York
INDENTURE, dated as of [ ], [ ] by and between Cyteir Therapeutics, Inc., a Delaware corporation, as Issuer (the “Company”) and U.S. Bank Trust Company, National Association, as Trustee (the “Trustee”).
ARTICLE 1. DEFINITIONS AND INCORPORATION BY REFERENCE 1 1.1. DEFINITIONS 1 1.2. INCORPORATION BY REFERENCE OF TRUST INDENTURE ACT 5 1.3. RULES OF CONSTRUCTION 5 ARTICLE 2. THE SECURITIES 6 2.1. ISSUABLE IN SERIES 6 2.2. ESTABLISHMENT OF TERMS OF...TransMedics Group, Inc. • August 3rd, 2022 • Electromedical & electrotherapeutic apparatus • New York
INDENTURE, dated as of [ ], [ ] by and between TransMedics Group, Inc., a Massachusetts corporation, as Issuer (the “Company”) and U.S. Bank Trust Company, National Association, as Trustee (the “Trustee”).
FINCH THERAPEUTICS GROUP, INC. and U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION, as Trustee INDENTURE Dated as of [ ], [ ]Finch Therapeutics Group, Inc. • May 24th, 2022 • Biological products, (no disgnostic substances) • New York
INDENTURE, dated as of [ ], [ ] by and between Finch Therapeutics Group, Inc., a Delaware corporation, as Issuer (the “Company”) and U.S. Bank Trust Company, National Association, as Trustee (the “Trustee”).
AnPac Bio-Medical Science Co., Ltd. and , as Trustee FORM OF INDENTURE Dated as of ,AnPac Bio-Medical Science Co., Ltd. • May 28th, 2021 • Services-medical laboratories • New York
INDENTURE, dated as of , , by and between AnPac Bio-Medical Science Co., Ltd., a company organized under the laws of the British Virgin Islands, as Issuer (the “Company”) and , a organized under the laws of , as Trustee (the “Trustee”).
CELCUITY INC. and ___________________, as Trustee INDENTURE Dated as of ___________, _______Celcuity Inc. • March 23rd, 2021 • Services-medical laboratories • New York
INDENTURE, dated as of , , by and between Celcuity Inc., a Delaware corporation, as Issuer (the “Company”) and _____________, a _______________________ organized under the laws of ________________, as Trustee (the “Trustee”).
INDONESIA ENERGY CORPORATION LIMITED and , as Trustee FORM OF INDENTURE Dated as of ,Indonesia Energy Corp LTD • January 28th, 2021 • Crude petroleum & natural gas • New York
SERVICENOW, INC. And WELLS FARGO BANK, NATIONAL ASSOCIATION, as Trustee INDENTURE Dated as of August 11, 2020 SENIOR DEBT SECURITIESServiceNow, Inc. • August 11th, 2020 • Services-prepackaged software • New York
INDENTURE, dated as of August 11, 2020, by and between ServiceNow, Inc., a Delaware corporation, as issuer (the “Company”) and Wells Fargo Bank, National Association, a national banking association duly organized and existing under the laws of the United States, as Trustee (the “Trustee”).
COLLEGIUM PHARMACEUTICAL, INC. and THE BANK OF NEW YORK MELLON TRUST COMPANY, N.A., as Trustee INDENTURE Dated as of February 13, 2020Collegium Pharmaceutical, Inc • February 13th, 2020 • Pharmaceutical preparations • New York
AKERS BIOSCIENCES, INC. and , as Trustee FORM OF INDENTURE Dated as of ,Akers Biosciences, Inc. • November 1st, 2019 • In vitro & in vivo diagnostic substances • New York
INDENTURE, dated as of , , by and between Akers Biosciences, Inc., a New Jersey corporation, as Issuer (the “Company”) and , a organized under the laws of , as Trustee (the “Trustee”).
CELLULAR BIOMEDICINE GROUP, INC. and , as Trustee FORM OF INDENTURE Dated as of ,Cellular Biomedicine Group, Inc. • July 5th, 2019 • Biological products, (no disgnostic substances) • New York
PAGE ARTICLE 1 DEFINITIONS AND INCORPORATION BY REFERENCE 1 1.1. DEFINITIONS 1 1.2. OTHER DEFINITIONS 4 1.3. INCORPORATION BY REFERENCE OF TRUST INDENTURE ACT 4 1.4. RULES OF CONSTRUCTION 5 ARTICLE 2 THE SECURITIES 5 2.1. ISSUABLE IN SERIES 5 2.2. ESTABLISHMENT OF TERMS OF SERIES OF SECURITIES 5 2.3. EXECUTION AND AUTHENTICATION 7 2.4. REGISTRAR AND PAYING AGENT 8 2.5. PAYING AGENT TO HOLD ASSETS IN TRUST 8 2.6. SECURITYHOLDER LISTS 9 2.7. TRANSFER AND EXCHANGE 9 2.8. REPLACEMENT SECURITIES 9 2.9. OUTSTANDING SECURITIES 9 2.10. WHEN TREASURY SECURITIES DISREGARDED; DETERMINATION OF HOLDERS’ ACTION 10 2.11. TEMPORARY SECURITIES 10 2.12. CANCELLATION 10 2.13. PAYMENT OF INTEREST; DEFAULTED INTEREST; COMPUTATION OF INTEREST 10 2.14. CUSIP NUMBER 11 2.15. PROVISIONS FOR GLOBAL SECURITIES 11 2.16. PERSONS DEEMED OWNERS 12 ARTICLE 3 REDEMPTION 12 3.1. NOTICES TO TRUSTEE 12 3.2. SELECTION BY TRUSTEE OF SECURITIES TO BE REDEEMED 12
CARDIOVASCULAR SYSTEMS, INC. and ___________________, as Trustee INDENTURE Dated as of ___________, _______Cardiovascular Systems Inc • December 6th, 2018 • Surgical & medical instruments & apparatus • New York
INDENTURE, dated as of , , by and between Cardiovascular Systems, Inc., a Delaware corporation, as Issuer (the “Company”) and , a organized under the laws of , as Trustee (the “Trustee”).
CHINA ADVANCED CONSTRUCTION MATERIALS GROUP, INC and , as Trustee FORM OF INDENTURE Dated as of ,China Advanced Construction Materials Group, Inc • June 18th, 2018 • Construction - special trade contractors • New York
CELLULAR BIOMEDICINE GROUP, INC. and , as Trustee FORM OF INDENTURE Dated as of ,Cellular Biomedicine Group, Inc. • March 23rd, 2016 • Biological products, (no disgnostic substances) • New York
PAGE ARTICLE 1 DEFINITIONS AND INCORPORATION BY REFERENCE 1 1.1. DEFINITIONS 1 1.2. OTHER DEFINITIONS 4 1.3. INCORPORATION BY REFERENCE OF TRUST INDENTURE ACT 4 1.4. RULES OF CONSTRUCTION 5 ARTICLE 2 THE SECURITIES 5 2.1. ISSUABLE IN SERIES 5 2.2. ESTABLISHMENT OF TERMS OF SERIES OF SECURITIES 5 2.3. EXECUTION AND AUTHENTICATION 7 2.4. REGISTRAR AND PAYING AGENT 8 2.5. PAYING AGENT TO HOLD ASSETS IN TRUST 8 2.6. SECURITYHOLDER LISTS 9 2.7. TRANSFER AND EXCHANGE 9 2.8. REPLACEMENT SECURITIES 9 2.9. OUTSTANDING SECURITIES 9 2.10. WHEN TREASURY SECURITIES DISREGARDED; DETERMINATION OF HOLDERS’ ACTION 10 2.11. TEMPORARY SECURITIES 10 2.12. CANCELLATION 10 2.13. PAYMENT OF INTEREST; DEFAULTED INTEREST; COMPUTATION OF INTEREST 10 2.14. CUSIP NUMBER 11 2.15. PROVISIONS FOR GLOBAL SECURITIES 11 2.16. PERSONS DEEMED OWNERS 12 ARTICLE 3 REDEMPTION 12 3.1. NOTICES TO TRUSTEE 12 3.2. SELECTION BY TRUSTEE OF SECURITIES TO BE REDEEMED 12
BIOGEN INC. and U.S. BANK NATIONAL ASSOCIATION, as Trustee INDENTURE Debt Securities Dated as of September 15, 2015Biogen Inc. • September 16th, 2015 • Biological products, (no disgnostic substances) • New York
INDENTURE, dated as of September 15, 2015, by and between Biogen Inc., a Delaware corporation, as Issuer (the “Company”), and U.S. Bank National Association, a national association, as Trustee (the “Trustee”).
BIOGEN INC. and U.S. BANK NATIONAL ASSOCIATION, as Trustee INDENTURE Debt Securities Dated as ofBiogen Inc. • September 8th, 2015 • Biological products, (no disgnostic substances) • New York
INDENTURE, dated as of , 20 , by and between Biogen Inc., a Delaware corporation, as Issuer (the “Company”), and U.S. Bank National Association, a national association, as Trustee (the “Trustee”).
AMYRIS, INC. And ___________________, as Trustee INDENTURE Dated as of ___________, _______Amyris, Inc. • April 2nd, 2015 • Industrial organic chemicals • New York
INDENTURE, dated as of , , by and between Amyris, Inc., a Delaware corporation, as Issuer (the “Company”) and , a organized under the laws of , as Trustee (the “Trustee”).
PAGE ARTICLE 1 DEFINITIONS AND INCORPORATION BY REFERENCE 1 1.1. DEFINITIONS 1 1.2. OTHER DEFINITIONS 4 1.3. INCORPORATION BY REFERENCE OF TRUST INDENTURE ACT 5 1.4. RULES OF CONSTRUCTION 5 ARTICLE 2 THE SECURITIES 5 2.1. ISSUABLE IN SERIES 5 2.2....Chelsea Therapeutics International, Ltd. • February 8th, 2012 • Biological products, (no disgnostic substances)
INDENTURE, dated as of , , by and between Chelsea Therapeutics International, Ltd., a Delaware corporation, as Issuer (the “Company”) and , a organized under the laws of , as Trustee (the “Trustee”).
Page ARTICLE 1 DEFINITIONS AND INCORPORATION BY REFERENCE 1 1.1. DEFINITIONS 1 1.2. OTHER DEFINITIONS 5 1.3. INCORPORATION BY REFERENCE OF TRUST INDENTURE ACT 6 1.4. RULES OF CONSTRUCTION 6 ARTICLE 2 THE SECURITIES 7 2.1. ISSUABLE IN SERIES 7 2.2....Lecroy Corp • August 15th, 2011 • Instruments for meas & testing of electricity & elec signals • New York
INDENTURE, dated as of ______________________, _______, by and between LeCroy Corporation, a Delaware corporation, as Issuer (the “Company”) and ____________________________, a ___________________________ organized under the laws of __________________________, as Trustee (the “Trustee”).
PAGE ARTICLE 1 DEFINITIONS AND INCORPORATION BY REFERENCE 1 1.1. DEFINITIONS 1 1.2. OTHER DEFINITIONS 4 1.3. INCORPORATION BY REFERENCE OF TRUST INDENTURE ACT 4 1.4. RULES OF CONSTRUCTION 5 ARTICLE 2 THE SECURITIES 5 2.1. ISSUABLE IN SERIES 5 2.2....Cardiovascular Systems Inc • June 3rd, 2011 • Surgical & medical instruments & apparatus • New York
INDENTURE, dated as of , , by and between Cardiovascular Systems, Inc., a Delaware corporation, as Issuer (the “Company”) and , a organized under the laws of , as Trustee (the “Trustee”).
Page ARTICLE 1 DEFINITIONS AND INCORPORATION BY REFERENCE 1 1.1. DEFINITIONS 1 1.2. OTHER DEFINITIONS 5 1.3. INCORPORATION BY REFERENCE OF TRUST INDENTURE ACT 6 1.4. RULES OF CONSTRUCTION 6 ARTICLE 2 THE SECURITIES 7 2.1. ISSUABLE IN SERIES 7 2.2....Lecroy Corp • September 24th, 2010 • Instruments for meas & testing of electricity & elec signals • New York
INDENTURE, dated as of ______________________, _______, by and between LeCroy Corporation, a Delaware corporation, as Issuer (the “Company”) and ____________________________, a ___________________________ organized under the laws of __________________________, as Trustee (the “Trustee”).
RUBICON TECHNOLOGY, INC. AND ____________________________________, AS TRUSTEE INDENTURE DATED AS OF __________, ____Rubicon Technology, Inc. • June 3rd, 2010 • Semiconductors & related devices • New York
INDENTURE, dated as of , , by and between Rubicon Technology, Inc., a Delaware corporation, as Issuer (the “Company”) and , a organized under the laws of , as Trustee (the “Trustee”).
RUBICON TECHNOLOGY, INC. AND ____________________________________, AS TRUSTEE INDENTURE DATED AS OF __________, ____Rubicon Technology, Inc. • January 12th, 2010 • Semiconductors & related devices • New York
INDENTURE, dated as of , , by and between Rubicon Technology, Inc., a Delaware corporation, as Issuer (the “Company”) and , a organized under the laws of , as Trustee (the “Trustee”).
PAGE ARTICLE 1 DEFINITIONS AND INCORPORATION BY REFERENCE 1 1.1. DEFINITIONS 1 1.2. OTHER DEFINITIONS 5 1.3. INCORPORATION BY REFERENCE OF TRUST INDENTURE ACT 6 1.4. RULES OF CONSTRUCTION 6 ARTICLE 2 THE SECURITIES 7 2.1. ISSUABLE IN SERIES 7 2.2....Targanta Therapeutics Corp. • November 18th, 2008 • Pharmaceutical preparations • New York
INDENTURE, dated as of ______________, ____, by and between Targanta Therapeutics Corporation, a Delaware corporation, as Issuer (the “Company”) and _____________________, a ________________ organized under the laws of _______________________, as Trustee (the “Trustee”).
GTC Biotherapeutics, Inc. and , as Trustee INDENTURE Dated as of ,GTC Biotherapeutics Inc • October 21st, 2005 • Biological products, (no disgnostic substances) • Massachusetts
INDENTURE, dated as of , , by and between GTC Biotherapeutics, Inc., a Massachusetts corporation, as Issuer (the “Company”), and , a organized under the laws of , as Trustee (the “Trustee”).
